Simpson Thacher recently represented Catalent, Inc., a portfolio company of The Blackstone Group L.P., in connection with its initial public offering of 42,500,000 shares of common stock at a public offering price of $20.50 per share. Catalent’s common stock began trading on the New York Stock Exchange under the ticker symbol “CTLT” on July 31, 2014. The underwriting syndicate was led by Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC. The offering raised approximately $871 million in gross proceeds. Catalent expects to use the net proceeds of the IPO to repay outstanding indebtedness.
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.
The Simpson Thacher team included: Ed Tolley, Xavier Kowalski and Hana Nah (Capital Markets); Peter Martelli and Lauren Colasacco (M&A); Brad Goldberg and Frank Kwok (Public Company Advisory Practice); Jonathan Karen and Carolyn Houston (Funds); Gary Mandel, Adam Wells and Jodi Sackel (Tax); Aimee Adler, Sarah Elliott, Nelli Zaltsman and Holly Gurian (Executive Compensation and Employee Benefits); Adeeb Fadil (Environmental); and Jennie Getsin (FINRA and Blue Sky).
